Safety of Antithymocyte Globulin Use in Kidney Graft Recipients During the COVID-19 Pandemic
Open Access
- 16 September 2021
- journal article
- research article
- Published by International Scientific Information, Inc. in Annals of Transplantation
- Vol. 26, e933001-1-e933001-6
- https://doi.org/10.12659/aot.933001
Abstract
Safety of Antithymocyte Globulin Use in Kidney Graft Recipients During the COVID-19 Pandemic - Article abstract #933001Keywords
This publication has 24 references indexed in Scilit:
- Infectious Complications of Induction Therapies in Kidney TransplantationAnnals of Transplantation, 2019
- Increased risk of rejection after basiliximab induction in sensitized kidney transplant recipients without pre‐existing donor‐specific antibodies – a retrospective studyTransplant International, 2019
- A paired kidney analysis on the impact of pre-transplant anti-HLA antibodies on graft survivalNephrology Dialysis Transplantation, 2018
- Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipientsEmergencias, 2017
- Rabbit antithymocyte globulin and donor-specific antibodies in kidney transplantation — A reviewTransplantation Reviews, 2016
- Clinical and economic analysis of short-course versus standard-course antithymocyte globulin (rabbit) induction therapy in deceased-donor renal transplant recipientsAmerican Journal of Health-System Pharmacy, 2011
- Rabbit Antithymocyte Globulin versus Basiliximab in Renal TransplantationThe New England Journal of Medicine, 2006
- LONG-TERM TOXICITY OF ANTITHYMOCYTE GLOBULIN INDUCTION MAY VARY WITH CHOICE OF AGENT: A SINGLE-CENTER RETROSPECTIVE STUDYTransplantation, 2004
- Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on cd3+ lymphocyte counts in kidney and kidney-pancreas transplant recipientsTransplantation, 2002
- Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring.1995